Personalized medicine became closer to reality in the last decade, as scientists mapped the human genome and made significant advances involving genetics and medicine. Since that time, the demand for those seeking diagnostic careers has expanded greatly, highlighting the value a clinical research staffing provider may provide to a diagnostic laboratory.
Dr. J. Craig Venter, whose eponymous research institute and privately-held company are among the leaders in the genomics industry, is no stranger to engaging in groundbreaking research surrounding genomics.
In 2001, he became one of the first to sequence the human genome and have his own genome sequenced. His team also sequenced genomes of the mouse, rat and fruit fly. In May 2010, he and a team of researchers produced the first cell with a synthetic genome.
He told The Charlotte Observer this week that he plans to continue to build off of his work with genomics to address societal problems. Many products that could be valuable to society, especially as a burgeoning population continues to tax many resources, may be able to be produced synthetically.
"We need tens of thousands of human genomes, not just one or a few, to begin to understand what our DNA can tell us and thus to begin to really see genomics advance medical treatments," Venter told the news source.
In addition to medical benefits, should Venter be able to harness the abilities of synthetic cells, he hopes that new food, vaccines, medicines and fuels will be able to be produced synthetically through this process.
In the interim, many laboratories desire progressive thinkers who are seeking diagnostic careers and clinical laboratory jobs. These individuals likely possess many of the same beliefs as Venter, which could prove valuable as the healthcare industry embraces personalized medicine as a means to address emerging health problems.
No related posts.
Comments
Powered by Facebook Comments